Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AXTI vs GSK✓SelectedUSD · GSKAXTI vs GSK performance historyLatest closeAs of-12.26%11/20
Stock and ETF performance explorer

AXTI vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+482.3%
GSK return
+97.4%
Excess return
+384.9%
Maximum drawdown
-92.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-12.3%-0.1%-12.1%-12.2%
7D-26.9%-5.3%-21.6%-25.9%
30D-48.4%-3.7%-44.8%-48.1%
3M-58.2%-7.3%-50.9%-57.6%
6M-70.8%-4.2%-66.5%-71.1%
YTD+87.0%+0.9%+86.1%+81.0%
1Y+223.5%+7.3%+216.2%+205.5%
3Y+1,391.2%+52.7%+1,338.5%+1,086.3%
5Y+247.0%+40.1%+206.9%+178.9%
All+482.3%+97.4%+384.9%+265.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling